References
- Coetzee G, Koornhof HJ. MDR/XDR tuberculosis in South Africa (Editorial) South Air J Epidemiol Infect2006; 21: 150–151
- Ghandi NR, Moll A, Sturm AW, Pawinski, R, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected Mth tuberculosis and HIV in a rural area in South Africa. Lancet2006; 368: 1575–1580
- Shah NS, Wright A, Bai G-H, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Os 2007, 13: 380–387
- Hiyam HE-H, Salvatore AE, Marras, E et al. Detection of rifampicin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Gun MicrobioI2001; 39: 4131–4137
- Traore H, Van Deun A, Shamputa IC, et al. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J Clin Microbiol 2006; 44: 4384–4388
- Hillemann D, Rüsch-Gerdes S, Richter E, et al. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Gun Microbiol 2007; 45:2635–2640
- Brossier F, Veziris N, Truffot-Pernot C, et al. Performance of the Genotype MTBDR line probe assay for detec-tion of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin MicrobioI2006; 44:3659–3664
- Barnard M, Albert H, Coetzee G, et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177:787–792